RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains

The Ewings Sarcoma Oncoprotein (EWS) interacts with several components of the mammalian transcriptional and pre-mRNA splicing machinery and is also found in the cytoplasm and even on the cell surface. The apparently diverse cellular functions of EWS are, however, not well characterized. EWS harbours a potent N-terminal transcriptional activation domain (the EAD) that is revealed in the context of oncogenic EWS-fusion proteins (EFPs) and a C-terminal RNA-binding domain (RBD) that recruits pre-mRNA splicing factors and may couple transcription and splicing. In contrast to EFPs, the presumed transcriptional role of normal EWS remains enigmatic. Here, we report that multiple RGG-boxes within the RBD are necessary and sufficient for cis-repression of the EAD and that RGG-boxes can also repress in-trans, within dimeric partners. Lys can functionally substitute for Arg, indicating that the basic nature of the Arg side chain is the critical determinant of RGG-box-mediated repression. In addition to the EAD, RGG-boxes can repress a broad range of activation domains (including those of VP16, E1a and CREB), but repression can be alleviated by the simultaneous presence of more than one activation domain. We therefore propose that a key function of RGG boxes within native EWS is to restrict promiscuous activation by the EAD while still allowing EWS to enter functional transcription complexes and participate in other transactions involving pre-mRNAs.

[1]  K K Li,et al.  Transcriptional Activation by the Ewing's Sarcoma (EWS) Oncogene Can Be Cis-repressed by the EWS RNA-binding Domain* , 2000, The Journal of Biological Chemistry.

[2]  D. Storm,et al.  The Prooncoprotein EWS Binds Calmodulin and Is Phosphorylated by Protein Kinase C through an IQ Domain* , 1997, The Journal of Biological Chemistry.

[3]  A. Falaschi,et al.  Human DNA helicase VIII: a DNA and RNA helicase corresponding to the G3BP protein, an element of the ras transduction pathway. , 1999, Nucleic acids research.

[4]  S. Baker,et al.  EWS/FLI Alters 5′-Splice Site Selection* , 2001, The Journal of Biological Chemistry.

[5]  C. Gunter,et al.  Purified Recombinant Fmrp Exhibits Selective RNA Binding as an Intrinsic Property of the Fragile X Mental Retardation Protein* , 1998, The Journal of Biological Chemistry.

[6]  N. Maizels,et al.  A Specific Isoform of hnRNP D Interacts with DNA in the LR1 Heterodimer: Canonical RNA Binding Motifs in a Sequence-specific Duplex DNA Binding Protein* , 1998, The Journal of Biological Chemistry.

[7]  K. A. Lee,et al.  Transcriptional regulation by CREB and its relatives. , 1993, Biochimica et biophysica acta.

[8]  B M Raaka,et al.  TLS (translocated-in-liposarcoma) is a high-affinity interactor for steroid, thyroid hormone, and retinoid receptors. , 1998, Molecular endocrinology.

[9]  K. Struhl,et al.  Synergistic transcriptional enhancement does not depend on the number of acidic activation domains bound to the promoter. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  L. Tora,et al.  The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties , 1999, Oncogene.

[11]  Jan Wijnholds,et al.  Cloning and characterisation of a nuclear, site specific ssDNA binding protein , 1995, Nucleic Acids Res..

[12]  K. A. Lee,et al.  Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene. , 1995, Oncogene.

[13]  C. Burd,et al.  Conserved structures and diversity of functions of RNA-binding proteins. , 1994, Science.

[14]  S. Pan,et al.  The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly , 1998, Oncogene.

[15]  M. Carey,et al.  Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA , 1992, Journal of virology.

[16]  J. Pelletier,et al.  Stimulation of hTAFII68 (NTD)‐mediated transactivation by v‐Src , 2004, FEBS letters.

[17]  Liang Feng,et al.  A repetitive element containing a critical tyrosine residue is required for transcriptional activation by the EWS/ATF1 oncogene , 2001, Oncogene.

[18]  H. Chansky,et al.  EWS·Fli-1 Fusion Protein Interacts with Hyperphosphorylated RNA Polymerase II and Interferes with Serine-Arginine Protein-mediated RNA Splicing* , 2000, The Journal of Biological Chemistry.

[19]  C. Burd,et al.  hnRNP proteins and the biogenesis of mRNA. , 1993, Annual review of biochemistry.

[20]  Huiqing Zhou,et al.  An hsRPB4/7-dependent yeast assay for trans-activation by the EWS oncogene , 2001, Oncogene.

[21]  Erica A Golemis,et al.  Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II , 1998, Oncogene.

[22]  Olivier Delattre,et al.  EWS, but Not EWS-FLI-1, Is Associated with Both TFIID and RNA Polymerase II: Interactions between Two Members of the TET Family, EWS and hTAFII68, and Subunits of TFIID and RNA Polymerase II Complexes , 1998, Molecular and Cellular Biology.

[23]  D. Immanuel,et al.  Association of SARFH (sarcoma-associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II , 1995, Molecular and cellular biology.

[24]  K. Williams,et al.  Identification of N(G)-methylarginine residues in human heterogeneous RNP protein A1: Phe/Gly-Gly-Gly-Arg-Gly-Gly-Gly/Phe is a preferred recognition motif. , 1997, Biochemistry.

[25]  D. Herschlag,et al.  Synergism in transcriptional activation: a kinetic view. , 1993, Genes & development.

[26]  M. Carey,et al.  A synergistic increase in potency of a multimerized VP16 transcriptional activation domain. , 1992, The EMBO journal.

[27]  N. Ohkura,et al.  The EWS/NOR1 Fusion Gene Product Gains a Novel Activity Affecting Pre-mRNA Splicing* , 2002, The Journal of Biological Chemistry.

[28]  S. Tsai,et al.  Oncoprotein TLS Interacts with Serine-Arginine Proteins Involved in RNA Splicing* , 1998, The Journal of Biological Chemistry.

[29]  R. Olsen,et al.  Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins , 2001, Oncogene.

[30]  Hurng‐Yi Wang,et al.  Structural diversity and functional implications of the eukaryotic TDP gene family. , 2004, Genomics.

[31]  L. Lee,et al.  The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. , 1996, Oncogene.

[32]  A. Ribeiro,et al.  An in vivo assay for members of the CREB family of transcription factors , 1994 .

[33]  Mariko Ariyoshi,et al.  A conserved structural motif reveals the essential transcriptional repression function of Spen proteins and their role in developmental signaling. , 2003, Genes & development.

[34]  William Arbuthnot Sir Lane,et al.  Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS , 1999, Current Biology.

[35]  S. Baker,et al.  The Splicing Factor U1C Represses EWS/FLI-mediated Transactivation* , 2000, The Journal of Biological Chemistry.

[36]  H. Kovar,et al.  The Ewing family of tumors and the search for the Achilles' heel. , 1999, Current opinion in oncology.

[37]  R. Janknecht,et al.  The Ewing's sarcoma gene product functions as a transcriptional activator. , 2001, Cancer research.

[38]  G. Dreyfuss,et al.  Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box. , 1992, The EMBO journal.

[39]  Neil J McKenna,et al.  A Steroid Receptor Coactivator, SRA, Functions as an RNA and Is Present in an SRC-1 Complex , 1999, Cell.

[40]  P. Gehrig,et al.  Exposure on Cell Surface and Extensive Arginine Methylation of Ewing Sarcoma (EWS) Protein* , 2001, The Journal of Biological Chemistry.

[41]  L. Freedman Increasing the Complexity of Coactivation in Nuclear Receptor Signaling , 1999, Cell.

[42]  C. Lorson,et al.  The Ewing's sarcoma protein interacts with the Tudor domain of the survival motor neuron protein. , 2003, Brain research. Molecular brain research.

[43]  G. Blobel,et al.  Physical and functional interaction between the transcriptional cofactor CBP and the KH domain protein Sam68. , 2002, Molecular Cancer Research.

[44]  D. Immanuel,et al.  TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. , 1997, Journal of cell science.

[45]  D. Brow,et al.  Control of pre-mRNA accumulation by the essential yeast protein Nrd1 requires high-affinity transcript binding and a domain implicated in RNA polymerase II association. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Ouchida,et al.  TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. , 1994, Oncogene.

[47]  K. A. Lee,et al.  A monomeric derivative of the cellular transcription factor CREB functions as a constitutive activator , 1994, Molecular and cellular biology.

[48]  A. Frankel,et al.  Specific binding of arginine to TAR RNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Leo M. Lee,et al.  EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function , 2001, Oncogene.

[50]  P. Chambon,et al.  hTAF(II)68, a novel RNA/ssDNA‐binding protein with homology to the pro‐oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. , 1996, The EMBO journal.

[51]  S. Barnache,et al.  The Transcription Factor Spi-1/PU.1 Interacts with the Potential Splicing Factor TLS* , 1998, The Journal of Biological Chemistry.

[52]  M. Montminy,et al.  Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Ouchida,et al.  The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. , 1994, Oncogene.

[54]  浦西 宏明 Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-κB p65-mediated transcription as a coactivator , 2002 .

[55]  G. Thomas,et al.  EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts , 1993, Nature Genetics.

[56]  J. Pelletier,et al.  Molecular genetics of chromosome translocations involving EWS and related family members. , 1999, Physiological genomics.

[57]  R. Brennan,et al.  Engineered leucine zippers show that hemiphosphorylated CREB complexes are transcriptionally active. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[58]  C. Orvain,et al.  Identification of an RNA Binding Specificity for the Potential Splicing Factor TLS* , 2001, The Journal of Biological Chemistry.

[59]  S. Haynes The RNP motif protein family. , 1992, The New biologist.

[60]  P. Raychaudhuri,et al.  trans-Activation by the hnRNP K Protein Involves an Increase in RNA Synthesis from the Reporter Genes (*) , 1996, The Journal of Biological Chemistry.

[61]  Christopher T Denny,et al.  Biology of EWS/ETS fusions in Ewing's family tumors , 2001, Oncogene.

[62]  G. Walter,et al.  Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen , 1984, Journal of virology.

[63]  P. DiMario,et al.  Deletion and site-specific mutagenesis of nucleolin's carboxy GAR domain , 2003, Chromosoma.

[64]  H. Handa,et al.  Evidence that Negative Elongation Factor Represses Transcription Elongation through Binding to a DRB Sensitivity-Inducing Factor/RNA Polymerase II Complex and RNA , 2002, Molecular and Cellular Biology.

[65]  V. Nikodem,et al.  hnRNP U Inhibits Carboxy-Terminal Domain Phosphorylation by TFIIH and Represses RNA Polymerase II Elongation , 1999, Molecular and Cellular Biology.

[66]  A. Fukamizu,et al.  Cooperative Interaction of EWS with CREB-binding Protein Selectively Activates Hepatocyte Nuclear Factor 4-mediated Transcription* , 2003, The Journal of Biological Chemistry.

[67]  H. Chansky,et al.  Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. , 2001, Cancer research.